St. Jude Medical Inc. is seeking a third-party stamp of approval on the safety of its Durata defibrillator leadsin an effort to get out ahead of growing questions in the clinical community based on safety issues with earlier-generation Riata leads.
The company will hand over raw data from three ongoing St. Jude-sponsored registries for the currently marketed Durata lead to...